Association of endothelial nitric oxide synthase gene polymorphisms with coronary artery disease: An updated meta-analysis and systematic review

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Rai, Himanshu ^a   Parveen, Farah ^a   Kumar, Sudeep ^a   Kapoor, Aditya ^a   Sinha, Nakul ^b  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b Medical Institute   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; CYTOSINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUTAMIC ACID; THYMINE; NOS3 PROTEIN, HUMAN;

AFRICAN; ALLELE; ANCESTRY GROUP; ASIAN; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE GENE; EUROPEAN; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC RISK; HETEROZYGOTE; HIGH RISK POPULATION; HUMAN; INDIAN; META ANALYSIS (TOPIC); MIDDLE EASTERN; NOS3 GENE; POPULATION GENETICS; RACE DIFFERENCE; REVIEW; SAMPLE SIZE; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW; VARIABLE NUMBER OF TANDEM REPEAT; ETHNIC GROUP; ETHNOLOGY; FACTUAL DATABASE; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; META ANALYSIS; ODDS RATIO; RISK FACTOR;

ALLELES; CORONARY ARTERY DISEASE; DATABASES, FACTUAL; ETHNIC GROUPS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; NITRIC OXIDE SYNTHASE TYPE III; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84912084767     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0113363     Document Type: Review

References (127)

1. Moncada S, Higgs A (1993) The L-arginine-nitric oxide pathway. N Engl J Med 329(27): 2002-2012.
2. Gardemann A, Lohre J, Cayci S, Katz N, Tillmanns H, et al. (2002) The T allele of the missense Glu(298)Asp endothelial nitric oxide synthase gene polymorphism is associated with coronary heart disease in younger individuals with high atherosclerotic risk profile. Atherosclerosis 160(1): 167-175.
3. Hingorani AD, Liang CF, Fatibene J, Lyon A, Monteith S, et al. (1999) A common variant of the endothelial nitric oxide synthase (Glu298 - >Asp) is a major risk factor for coronary artery disease in the UK. Circulation 100(14): 1515-1520.
4. Colombo MG, Andreassi MG, Paradossi U, Botto N, Manfredi S, et al. (2002) Evidence for association of a common variant of the endothelial nitric oxide synthase gene (Glu298 - >Asp polymorphism) to the presence, extent, and severity of coronary artery disease. Heart 87(6): 525-528.
5. Colombo MG, Paradossi U, Andreassi MG, Botto N, Manfredi S, et al. (2003) Endothelial nitric oxide synthase gene polymorphisms and risk of coronary artery disease. Clin Chem 49(3): 389-395.
6. Marsden PA, Heng HH, Scherer SW, Stewart RJ, Hall AV, et al. (1993) Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J Biol Chem 268(23): 17478-17488.
7. Hingorani A, Jia H, Stevens P, Monteith M, Brown M (1995) A Common Variant in Exon 7 of the Endothelial Constitutive Nitric Oxide Synthase Gene: Identification by Single Strand Conformation Polymorphism Analysis. Clinical Science 88(Pt s32): 21P-21P. (Abstract).
8. Yoshimura M, Yasue H, Nakayama M, Shimasaki Y, Sumida H, et al. (1998) A missense Glu298Asp variant in the endothelial nitric oxide synthase gene is associated with coronary spasm in the Japanese. Hum Genet 103(1): 65-69.
9. Miyamoto Y, Saito Y, Kajiyama N, Yoshimura M, Shimasaki Y, et al. (1998) Endothelial nitric oxide synthase gene is positively associated with essential hypertension. Hypertension 32(1): 3-8.
10. Shimasaki Y, Yasue H, Yoshimura M, Nakayama M, Kugiyama K, et al. (1998) Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with myocardial infarction. J Am Coll Cardiol 31(7): 1506-1510.
11. Hibi K, Ishigami T, Tamura K, Mizushima S, Nyui N, et al. (1998) Endothelial nitric oxide synthase gene polymorphism and acute myocardial infarction. Hypertension 32(3): 521-526.
12. Philip I, Plantefeve G, Vuillaumier-Barrot S, Vicaut E, LeMarie C, et al. (1999) G894T polymorphism in the endothelial nitric oxide synthase gene is associated with an enhanced vascular responsiveness to phenylephrine. Circulation 99(24): 3096-3098.
13. Angeline T, Isabel W, Tsongalis GJ (2010) Endothelial nitric oxide gene polymorphisms, nitric oxide production and coronary artery disease risk in a South Indian population. Exp Mol Pathol 89(3): 205-208.
14. Bor-Kucukatay M, Demir S, Akbay R, Dursunoglu D, Akdag B, et al. (2010) Relationship between hemorheology and Glu(298)Asp polymorphism of endothelial nitric oxide synthase gene in patients with coronary artery disease. Mol Biol Rep 37(1): 171-178.
15. Dafni C, Drakoulis N, Landt O, Panidis D, Reczko M, et al. (2010) Association of the eNOS E298D polymorphism and the risk of myocardial infarction in the Greek population. BMC Med Genet 11: 133.
16. Salimi S, Firoozrai M, Zand H, Nakhaee A, Shafiee SM, et al. (2010) Endothelial nitric oxide synthase gene Glu298Asp polymorphism in patients with coronary artery disease. Ann Saudi Med 30(1): 33-37.
17. Salimi S, Naghavi A, Firoozrai M, Zand H, Tavilani H, et al. (2012) Association of plasma nitric oxide concentration and endothelial nitric oxide synthase T-786C gene polymorphism in coronary artery disease. Pathophysiology 19(3): 157-162.
18. Cai H, Wilcken DE, Wang XL (1999) The Glu-298 - >Asp (894G - >T) mutation at exon 7 of the endothelial nitric oxide synthase gene and coronary artery disease. J Mol Med (Berl) 77(6): 511-514.
19. Nassar BA, Bevin LD, Johnstone DE, O'Neill B J, Bata IR, et al. (2001) Relationship of the Glu298Asp polymorphism of the endothelial nitric oxide synthase gene and early-onset coronary artery disease. Am Heart J 142(4): 586-589.
20. Schmoelzer I, Renner W, Paulweber B, Malaimare L, Iglseder B, et al. (2003) Lack of association of the Glu298Asp polymorphism of endothelial nitric oxide synthase with manifest coronary artery disease, carotid atherosclerosis and forearm vascular reactivity in two Austrian populations. Eur J Clin Invest 33(3): 191-198.
21. Jaramillo PC, Munoz MA, Lanas MC, Lanas ZF, Salazar LA (2006) Endothelial nitric oxide synthase G894T gene polymorphism in Chilean subjects with coronary artery disease and controls. Clin Chim Acta 371(1-2): 102-106.
22. Kim IJ, Bae J, Lim SW, Cha DH, Cho HJ, et al. (2007) Influence of endothelial nitric oxide synthase gene polymorphisms (-786T>C, 4a4b, 894G>T) in Korean patients with coronary artery disease. Thromb Res 119(5): 579-585.
23. Alp E, Menevse S, Tulmac M, Kan D, Yalcin R, et al. (2009) Lack of association between matrix metalloproteinase-9 and endothelial nitric oxide synthase gene polymorphisms and coronary artery disease in Turkish population. DNA Cell Biol 28(7): 343-350.
24. Nakayama M, Yasue H, Yoshimura M, Shimasaki Y, Kugiyama K, et al. (1999) T-786 - >C mutation in the 5′-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation 99(22): 2864-2870.
25. Sandrim VC, de Syllos RW, Lisboa HR, Tres GS, Tanus-Santos JE (2006) Endothelial nitric oxide synthase haplotypes affect the susceptibility to hypertension in patients with type 2 diabetes mellitus. Atherosclerosis 189(1): 241-246.
26. Miyamoto Y, Saito Y, Nakayama M, Shimasaki Y, Yoshimura T, et al. (2000) Replication protein A1 reduces transcription of the endothelial nitric oxide synthase gene containing a -786T - >C mutation associated with coronary spastic angina. Hum Mol Genet 9(18): 2629-2637.
27. Alvarez R, Gonzalez P, Batalla A, Reguero JR, Iglesias-Cubero G, et al. (2001) Association between the NOS3 (-786 T/C) and the ACE (I/D) DNA genotypes and early coronary artery disease. Nitric Oxide 5(4): 343-348.
28. Rios DL, Callegari-Jacques SM, Hutz MH (2005) Endothelial nitric oxide synthase and fractalkine chemokine receptor polymorphisms on angiographically assessed coronary atherosclerosis. Clin Chim Acta 362(1-2): 138-146.
29. Hyndman ME, Parsons HG, Verma S, Bridge PJ, Edworthy S, et al. (2002) The T-786 - >C mutation in endothelial nitric oxide synthase is associated with hypertension. Hypertension 39(4): 919-922.
30. Rossi GP, Cesari M, Zanchetta M, Colonna S, Maiolino G, et al. (2003) The T-786C endothelial nitric oxide synthase genotype is a novel risk factor for coronary artery disease in Caucasian patients of the GENICA study. J Am Coll Cardiol 41(6): 930-937.
31. Nakayama M, Yasue H, Yoshimura M, Shimasaki Y, Ogawa H, et al. (2000) T(-786) - >C mutation in the 5′-flanking region of the endothelial nitric oxide synthase gene is associated with myocardial infarction, especially without coronary organic stenosis. Am J Cardiol 86(6): 628-634.
32. Ragia G, Nikolaidis E, Tavridou A, Arvanitidis KI, Kanoni S, et al. (2010) Endothelial nitric oxide synthase gene polymorphisms -786T>C and 894G>T in coronary artery bypass graft surgery patients. Hum Genomics 4(6): 375-383.
33. Wang XL, Sim AS, Badenhop RF, McCredie RM, Wilcken DE (1996) A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nat Med 2(1): 41-45.
34. Cine N, Hatemi AC, Erginel-Unaltuna N (2002) Association of a polymorphism of the ecNOS gene with myocardial infarction in a subgroup of Turkish MI patients. Clin Genet 61(1): 66-70.
35. Ichihara S, Yamada Y, Fujimura T, Nakashima N, Yokota M (1998) Association of a polymorphism of the endothelial constitutive nitric oxide synthase gene with myocardial infarction in the Japanese population. Am J Cardiol 81(1): 83-86.
36. Park JE, Lee WH, Hwang TH, Chu JA, Kim S, et al. (2000) Aging affects the association between endothelial nitric oxide synthase gene polymorphism and acute myocardial infarction in the Korean male population. Korean J Intern Med 15(1): 65-70.
37. Granath B, Taylor RR, van Bockxmeer FM, Mamotte CD (2001) Lack of evidence for association between endothelial nitric oxide synthase gene polymorphisms and coronary artery disease in the Australian Caucasian population. J Cardiovasc Risk 8(4): 235-241.
38. Poirier O, Mao C, Mallet C, Nicaud V, Herrmann SM, et al. (1999) Polymorphisms of the endothelial nitric oxide synthase gene - no consistent association with myocardial infarction in the ECTIM study. Eur J Clin Invest 29(4): 284-290.
39. Jaramillo PC, Lanas C, Lanas F, Salazar LA (2010) Polymorphisms of the NOS3 gene in Southern Chilean subjects with coronary artery disease and controls. Clin Chim Acta 411(3-4): 258-262.
40. Li J, Wu X, Li X, Feng G, He L, et al. (2010) The endothelial nitric oxide synthase gene is associated with coronary artery disease: a meta-analysis. Cardiology 116(4): 271-278.
41. Zhang K, Bai P, Shi S, Zhou B, Wang Y, et al. (2012) The G894T polymorphism on endothelial nitric oxide synthase gene is associated with increased coronary heart disease among Asia population: evidence from a Meta analysis. Thromb Res 130(2): 192-197.
42. Liu D, Jiang Z, Dai L, Zhang X, Yan C, et al. (2013) Association between the -786T>C 1polymorphism in the promoter region of endothelial nitric oxide synthase (eNOS) and risk of coronary artery disease: A systematic review and meta-analysis. Gene pii: S0378-1119(13)01333-4.
43. Tian GX, Zeng XT, Wang XB, Zhang L, Zhang W, et al. (2013) Association between the endothelial nitric oxide synthase gene Glu298Asp polymorphism and coronary heart disease: a metaanalysis of 39 casecontrol studies. Mol Med Rep 7(4): 1310-1318.
44. Yang Y, Du K, Liu Z, Lu X (2014). Endothelial nitric oxide synthase (eNOS) 4b/a gene polymorphisms and coronary artery disease: evidence from a meta-analysis. Int J Mol Sci 15(5): 7987-8003.
45. Panic N, Leoncini E, de Belvis G, Ricciardi W, Boccia S (2013) Evaluation of the endorsement of the preferred reporting items for systematic reviews and meta-analysis (PRISMA) statement on the quality of published systematic review and meta-analyses. PLoS One 8(12): e83138.
46. Lewis CM (2002) Genetic association studies: design, analysis and interpretation. Brief Bioinform 3(2): 146-153.
47. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3): 177-188.
48. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22(4): 719-748.
49. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. Bmj 327(7414): 557-560.
50. Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50(4): 1088-1101.
51. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. Bmj 315(7109): 629-634.
52. Clayton D, McKeigue PM (2001) Epidemiological methods for studying genes and environmental factors in complex diseases. The Lancet 358(9290): 1356-1360.
53. Pulkkinen A, Viitanen L, Kareinen A, Lehto S, Vauhkonen I, et al. (2000) Intron 4 polymorphism of the endothelial nitric oxide synthase gene is associated with elevated blood pressure in type 2 diabetic patients with coronary heart disease. J Mol Med (Berl) 78(7): 372-379.
54. Agema WR, de Maat MP, Zwinderman AH, Kastelein JJ, Rabelink TJ, et al. (2004) An integrated evaluation of endothelial constitutive nitric oxide synthase polymorphisms and coronary artery disease in men. Clin Sci (Lond) 107(3): 255-261.
55. Fatini C, Sofi F, Sticchi E, Gensini F, Gori AM, et al. (2004) Influence of endothelial nitric oxide synthase gene polymorphisms (G894T, 4a4b, T-786C) and hyperhomocysteinemia on the predisposition to acute coronary syndromes. Am Heart J.147(3): 516-521.
56. Antoniades C, Tousoulis D, Vasiliadou C, Pitsavos C, Chrysochoou C, et al. (2005) Genetic polymorphism on endothelial nitric oxide synthase affects endothelial activation and inflammatory response during the acute phase of myocardial infarction. J Am Coll Cardiol.46(6): 1101-1109.
57. Rios DL, D'Onofrio LO, Souza JK, Queiroz AM, Raduy-Maron L, et al. (2007) Smoking-dependent and haplotype-specific effects of endothelial nitric oxide synthase gene polymorphisms on angiographically assessed coronary artery disease in Caucasian- and African-Brazilians. Atherosclerosis 193(1): 135-41.
58. Sampaio MF, Hirata MH, Hirata RD, Santos FC, Picciotti R. et al. (2007) AMI is associated with polymorphisms in the NOS3 and FGB but not in PAI-1 genes in young adults. Clin Chim Acta 377(1-2): 154-162.
59. Andrikopoulos GK, Grammatopoulos DK, Tzeis SE, Zervou SI, Richter DJ, et al. (2008) Association of the 894G>T polymorphism in the endothelial nitric oxide synthase gene with risk of acute myocardial infarction. BMC Med Genet 9: 43.
60. Szperl M, Dzielinska Z, Roszczynko M, Malek LA, Makowiecka-Ciesla M, et al. (2008) Genetic variants in hypertensive patients with coronary artery disease and coexisting atheromatous renal artery stenosis. Med Sci Monit 14(12): Cr611-616.
61. Vasilakou M, Votteas V, Kasparian C, Pantazopoulos N, Dedoussis G, et al. (2008) Lack of association between endothelial nitric oxide synthase gene polymorphisms and risk of premature coronary artery disease in the Greek population. Acta Cardiol 63(5): 609-614.
62. Gluba A, Banach M, Rysz J, Piotrowski G, Fendler W, et al. (2009) Is polymorphism within eNOS gene associated with the late onset of myocardial infarction? A pilot study. Angiology 60(5): 588-595.
63. Isordia-Salas I, Leanos-Miranda A, Borrayo-Sanchez G (2010) The Glu298Asp polymorphism of the endothelial nitric oxide synthase gene is associated with premature ST elevation myocardial infarction in Mexican population. Clin Chim Acta 411(7-8): 553-557.
64. da Costa Escobar Piccoli J, Manfredini V, Hamester FI, Bandinelli JB, Turkienicz IM, et al. (2012) Interaction between endothelial nitric oxide synthase gene polymorphisms (-786T>C, 894G>T and intron 4 a/b) and cardiovascular risk factors in acute coronary syndromes. Arch Med Res 43(3): 205-11.
65. Zigra AM, Rallidis LS, Anastasiou G, Merkouri E, Gialeraki A (2013) eNOS gene variants and the risk of premature myocardial infarction. Dis Markers 34(6): 431-436.
66. Aras O, Hanson NQ, Bakanay SM, Tsai MY, Gulec S (2002) Endothelial nitric oxide gene polymorphism (Glu298Asp) is not associated with coronary artery disease in Turkish population. Thromb Haemost;87(2): 347-349.
67. Afrasyap L, Ozturk G (2004) NO level and endothelial NO synthase gene polymorphism (Glu298Asp) in the patients with coronary artery disease from the Turkish population. Acta Biochim Biophys Sin (Shanghai) 36(10): 661-666.
68. Berdeli A, Sekuri C, Sirri Cam F, Ercan E, Sagcan A., et al. (2005) Association between the eNOS (Glu298Asp) and the RAS genes polymorphisms and premature coronary artery disease in a Turkish population. Clin Chim Acta 351(1-2): 87-94.
69. Cam SF, Sekuri C, Tengiz I, Ercan E, Sagcan A., et al. (2005) The G894T polymorphism on endothelial nitric oxide synthase gene is associated with premature coronary artery disease in a Turkish population. Thromb Res 116(4): 287-292.
70. Kerkeni M, Addad F, Chauffert M, Myara A, Ben Farhat M, et al. (2006) Hyperhomocysteinemia, endothelial nitric oxide synthase polymorphism, and risk of coronary artery disease. Clin Chem 52(1): 53-58.
71. Alkharfy KM, Al-Daghri NM, Al-Attas OS, Alokail MS, Draz HM, et al. (2010) Endothelial nitric oxide synthase gene polymorphisms (894G>T and -786T>C) and risk of coronary artery disease in a Saudi population. Arch Med Res 41(2): 134-141.
72. Motawi T, Shaker O, Taha M, Sedrak H, Nabil M (2011) Endothelial nitric oxide synthase and angiotensinogen gene polymorphism in coronary artery diseases in Egypt. Angiology 62(2):191-7.
73. Gad MZ, Abdel Rahman MF, Hashad IM, Abdel-Maksoud SM, Farag NM, et al. (2012) Endothelial nitric oxide synthase (G894T) gene polymorphism in a random sample of the Egyptian population: comparison with myocardial infarction patients. Genet Test Mol Biomarkers 16(7): 695-700.
74. Rahimi Z, Nourozi-Rad R (2012) Association of endothelial nitric oxide synthase gene variant (G894T) with coronary artery disease in Western Iran. Angiology 63(2): 131-137.
75. Abdel-Aziz TA, Mohamed RH (2013) Association of endothelial nitric oxide synthase gene polymorphisms with classical risk factors in development of premature coronary artery disease. Mol Biol Rep 40(4): 3065-3071.
76. Kallel A, Sbai MH, Sediri Y, Abdessalem S, Mourali MS, et al. (2013) Polymorphisms of the NOS3 gene and risk of myocardial infarction in the Tunisian population. Cytokine 64(3): 646-651.
77. Yoon Y, Song J, Hong SH, Kim JQ (2000) Plasma nitric oxide concentrations and nitric oxide synthase gene polymorphisms in coronary artery disease. Clin Chem 46(10): 1626-1630.
78. Wang CL, Hsu LA, Ko YS, Ko YL, Lee YH (2001) Lack of association between the Glu298Asp variant of the endothelial nitric oxide synthase gene and the risk of coronary artery disease among Taiwanese. J Formos Med Assoc 100(11): 736-740.
79. Jo I, Moon J, Yoon S, Kim HT, Kim E, et al. (2006) Interaction between -786TC polymorphism in the endothelial nitric oxide synthase gene and smoking for myocardial infarction in Korean population. Clin Chim Acta 365(1-2):86-92.
80. Lin NT, Lee MJ, Lee RP, Hong AI, Chen HI (2008) Analysis of endothelial nitric oxide synthase gene polymorphisms with cardiovascular diseases in eastern Taiwan. Chin J Physiol 51(1): 42-47.
81. Tamemoto H, Ishikawa SE, Kawakami M (2008) Association of the Glu298Asp polymorphism of the eNOS Gene with ischemic heart disease in Japanese diabetic subjects. Diabetes Res Clin Pract 80(2): 275-279.
82. Bae J, Kim IJ, Hong SH, Sung JH, Lim SW, et al. (2010) Association of endothelial nitric oxide synthase polymorphisms with coronary artery disease in Korean individuals with or without diabetes mellitus. Exp Ther Med 1(4): 719-724.
83. Min BW, Na JY, Juhng SW, Park MS, Park JT, et al. (2010) A polymorphism (G894T) in eNOS increases the risk of coronary atherosclerosis rather than intracranial atherosclerosis in Koreans. Acta Neurol Belg 110(3): 255-262.
84. Mathew J, Narayanan P, Sundaram R, Jayaraman B, Dutta TK, et al. (2008) Lack of association between Glu(298) asp polymorphism of endothelial nitric oxide synthase (eNOS) gene and coronary artery disease in Tamilian population. Indian Heart J 60(3): 223-227.
85. Bhanushali AA, Das BR (2010) Genetic variants at the APOE, lipoprotein lipase (LpL), cholesteryl ester transfer protein (CETP), and endothelial nitric oxide (eNOS) genes and coronary artery disease (CAD): CETP Taq1 B2B2 associates with lower risk of CAD in Asian Indians. J Community Genet 1(2): 55-62.
86. Saini V, Bhatnagar MK, Bhattacharjee J (2011) Association of endothelial dysfunction with endothelin, nitric oxide and eNOS Glu298Asp gene polymorphism in coronary artery disease. Dis Markers 31(4): 215-22.
87. Rai H, Fitt J, Sharma AK, Sinha N, Kumar S, et al. (2012) Lack of association between Glu298Asp polymorphism and coronary artery disease in North Indians. Mol Biol Rep 39(5): 5995-6000.
88. Saini V, Bhatnagar MK, Bhattacharjee J (2012) Endothelial nitric oxide synthase Glu298Asp (G894T) gene polymorphism in coronary artery disease patients with type 2 diabetes mellitus. Diabetes Metab Syndr 6(2): 106-9.
89. Arun Kumar AS, Umamaheswaran G, Padmapriya R, Balachandar J, Adithan C (2013) Endothelial nitric oxide synthase gene polymorphisms and the risk of acute myocardial infarction in a South Indian population. Mol Biol Rep 40(2): 1275-81.
90. Narne P, Ponnaluri KC, Singh S, Siraj M, Ishaq M (2013) Association of the genetic variants of endothelial nitric oxide synthase gene with angiographically defined coronary artery disease and myocardial infarction in South Indian patients with type 2 diabetes mellitus. J Diabetes Complications 27(3): 255-261.
91. Dosenko VE, Zagoriy VY, Lutay YM, Parkhomenko AN, Moibenko AA (2006) Allelic polymorphism in the promoter (T - >C), but not in exon 7 (G - >T) or the variable number tandem repeat in intron 4, of the endothelial nitric oxide synthase gene is positively associated with acute coronary syndrome in the Ukrainian population. Exp Clin Cardiol 11(1): 11-13.
92. Jaramillo PC, Lanas C, Lanas F, Salazar LA (2008) -786T>C polymorphism of the endothelial nitric oxide synthase gene in Chilean subjects with coronary artery disease and controls. Clin Chim Acta 387(1-2): 105-108.
93. Meluzin J, Vasku A, Kincl V, Panovsky R, Sramkova T (2009) Association of coronary artery disease, erectile dysfunction, and endothelial nitric oxide synthase polymorphisms. Heart Vessels 24(3): 157-163.
94. Tangurek B, Ozer N, Sayar N, Terzi S, Yilmaz H, et al. (2006) The relationship between endothelial nitric oxide synthase gene polymorphism (T-786 C) and coronary artery disease in the Turkish population. Heart Vessels 21(5): 285-290.
95. Ciftci C, Melil S, Cebi Y, Ersoz M, Cagatay P, et al. (2008) Association of endothelial nitric oxide synthase promoter region (T-786C) gene polymorphism with acute coronary syndrome and coronary heart disease. Lipids Health Dis 7: 5.
96. Takagi S, Goto Y, Nonogi H, Baba S, Iwai N (2001) Genetic polymorphisms of angiotensin converting enzyme (I/D) and endothelial nitric oxide synthase (T(-788)C) genes in Japanese patients with myocardial infarction. Thromb Haemost Germany p. 1339-40.
97. Han Y, Xu W, Zhang W, Liu N, Ji Y (2010) T-786C polymorphism in the endothelial nitric oxide synthase gene is associated with increased risk of coronary artery disease in a Chinese population. Pharmacology 85(4): 211-216.
98. Hooper WC, Lally C, Austin H, Benson J, Dilley A, et al. (1999) The relationship between polymorphisms in the endothelial cell nitric oxide synthase gene and the platelet GPIIIa gene with myocardial infarction and venous thromboembolism in African Americans. Chest 116(4): 880-6.
99. Fowkes FG, Lee AJ, Hau CM, Cooke A, Connor JM, et al. (2000) Methylene tetrahydrofolate reductase (MTHFR) and nitric oxide synthase (ecNOS) genes and risks of peripheral arterial disease and coronary heart disease: Edinburgh Artery Study. Atherosclerosis 150(1): 179-185.
100. Pulkkinen A, Viitanen L, Kareinen A, Lehto S, Vauhkonen I, et al. (2000) Intron 4 polymorphism of the endothelial nitric oxide synthase gene is associated with elevated blood pressure in type 2 diabetic patients with coronary heart disease. J Mol Med (Berl) 78(7): 372-379.
101. Sigusch HH, Surber R, Lehmann MH, Surber S, Weber J, et al. (2000) Lack of association between 27-bp repeat polymorphism in intron 4 of the endothelial nitric oxide synthase gene and the risk of coronary artery disease. Scand J Clin Lab Invest 60(3): 229-235.
102. Letonja M (2004) The eNOS gene polymorphism does not have a major impact on lipid parameters and premature coronary artery disease in Caucasian women. Acta Cardiol 59(6): 618-622.
103. Milutinovic A, Hruskovicova H (2005) The eNOS gene polymorphism does not have a major impact on lipid parameters and premature coronary artery disease in Slovene men (Caucasians). Folia Biol (Praha) 51(2): 47-49.
104. Rao S, Austin H, Davidoff MN, Zafari AM (2005) Endothelial nitric oxide synthase intron 4 polymorphism is a marker for coronary artery disease in African-American and Caucasian men. Ethn Dis 15(2): 191-7.
105. Kincl V, Vasku A, Meluzin J, Panovsky R, Semenka J, et al. (2009) Association of the eNOS 4a/b and -786T/C polymormphisms with coronary artery disease, obesity and diabetes mellitus. Folia Biol (Praha) 55(5): 187-191.
106. Matyar S, Attila G, Acarturk E, Akpinar O, Inal T (2005) eNOS gene intron 4 a/b VNTR polymorphism is a risk factor for coronary artery disease in Southern Turkey. Clin Chim Acta 354(1-2): 153-158.
107. Agirbasli D, Agirbasli M, Williams SM, Phillips JA 3rd (2006) Interaction among 5,10 methylenetetrahydrofolate reductase, plasminogen activator inhibitor and endothelial nitric oxide synthase gene polymorphisms predicts the severity of coronary artery disease in Turkish patients. Coron Artery Dis 17(5): 413-417.
108. Agirbasli M, Guney AI, Ozturhan HS, Agirbasli D, Ulucan K., et al. (2011) Multifactor dimensionality reduction analysis of MTHFR, PAI-1, ACE, PON1, and eNOS gene polymorphisms in patients with early onset coronary artery disease. Eur J Cardiovasc Prev Rehabil 18(6): 803-809.
109. Salimi S, Firoozrai M, Nourmohammadi I, Shabani M, Mohebbi A (2006) Endothelial nitric oxide synthase gene intron4 VNTR polymorphism in patients with coronary artery disease in Iran. Indian J Med Res 124(6): 683-688.
110. Jemaa R, Kallel A, Ben Ali S, Omar S, Chabrak S, et al. (2007) Association of a 27-bp repeat polymorphism in intron 4 of endothelial constitutive nitric oxide synthase gene with myocardial infarction in Tunisian patients. Clin Chem Lab Med 45(11): 1476-80.
111. Ekmekci A, Ozcan KS, Gungor B, Abaci N, Osmonov D., et al. (2013) The relationship between endothelial nitric oxide synthase 4a/4b gene polymorphism and premature coronary artery disease. Acta Cardiol 68(5): 464-468.
112. Odawara M, Sasaki K, Tachi Y, Yamashita K (1998) Endothelial nitric oxide synthase gene polymorphism and coronary heart disease in Japanese NIDDM. Diabetologia 41(3): 365-366.
113. Nakagami H, Ikeda U, Maeda Y, Yamamoto K, Hojo Y, et al. (1999) Coronary artery disease and endothelial nitric oxide synthase and angiotensin-converting enzyme gene polymorphisms. J Thromb Thrombolysis 8(3): 191-5.
114. Lee WH, Hwang TH, Oh GT, Kwon SU, Choi YH, et al. (2001) Genetic factors associated with endothelial dysfunction affect the early onset of coronary artery disease in Korean males. Vasc Med 6(2): 103-108.
115. Hwang JJ, Tsai CT, Yeh HM, Chiang FT, Hsu KL, et al. (2002) The 27-bp tandem repeat polymorphism in intron 4 of the endothelial nitric oxide synthase gene is not associated with coronary artery disease in a hospital-based Taiwanese population. Cardiology 97(2): 67-72.
116. Gururajan P, Gurumurthy P, Victor D, Srinivasa Nageswara Rao G, Sai Babu R, et al. (2011) Plasma total nitric oxide and endothelial constitutive nitric oxide synthase (ecNOS) gene polymorphism: a study in a South Indian population. Biochem Genet 49(1-2): 96-103.
117. Salom MG, Arregui B, Carbonell LF, Ruiz F, Gonzalez-Mora JL, et al. (2005) Renal ischemia induces an increase in nitric oxide levels from tissue stores. Am J Physiol Regul Integr Comp Physiol 289(5): R1459-1466.
118. Kelm M, Feelisch M, Deussen A, Strauer BE, Schrader J (1991) Release of endothelium derived nitric oxide in relation to pressure and flow. Cardiovasc Res 25(10): 831-836.
119. Tesauro M, Thompson WC, Rogliani P, Qi L, Chaudhary PP, et al. (2000) Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298. Proc Natl Acad Sci U S A 97(6): 2832-2835.
120. Persu A, Stoenoiu MS, Messiaen T, Davila S, Robino C, et al. (2002) Modifier effect of ENOS in autosomal dominant polycystic kidney disease. Hum Mol Genet. 11(3): 229-241.
121. Rankinen T, Rice T, Perusse L, Chagnon YC, Gagnon J, et al. (2000) NOS3 Glu298Asp genotype and blood pressure response to endurance training: the HERITAGE family study. Hypertension 36(5): 885-889.
122. Naber CK, Baumgart D, Altmann C, Siffert W, Erbel R, et al. (2001) eNOS 894T allele and coronary blood flow at rest and during adenosine-induced hyperemia. Am J Physiol Heart Circ Physiol 281(5): H1908-1912.
123. Savvidou MD, Vallance PJ, Nicolaides KH, Hingorani AD (2001) Endothelial nitric oxide synthase gene polymorphism and maternal vascular adaptation to pregnancy. Hypertension 38(6): 1289-1293.
124. Jeerooburkhan N, Jones LC, Bujac S, Cooper JA, Miller GJ, et al. (2001) Genetic and environmental determinants of plasma nitrogen oxides and risk of ischemic heart disease. Hypertension 38(5): 1054-1061.
125. Tsukada T, Yokoyama K, Arai T, Takemoto F, Hara S, et al. (1998) Evidence of association of the ecNOS gene polymorphism with plasma NO metabolite levels in humans. Biochem Biophys Res Commun 245(1): 190-193.
126. Wang XL, Sim AS, Wang MX, Murrell GA, Trudinger B, et al. (2000) Genotype dependent and cigarette specific effects on endothelial nitric oxide synthase gene expression and enzyme activity. FEBS Lett 471(1): 45-50.
127. Wang XL, Mahaney MC, Sim AS, Wang J, Wang J., et al. (1997) Genetic contribution of the endothelial constitutive nitric oxide synthase gene to plasma nitric oxide levels. Arterioscler Thromb Vasc Biol 17(11): 3147-3153.